Rising Cases of Vision Disorders Worldwide Augmenting Sales of Vitreous Tamponades: Fact.MR Analysis

December 22, 2022

Rockville, Dec. 22, 2022 (GLOBE NEWSWIRE) -- As per a new industry analysis by Fact.MR, a market research and competitive intelligence provider, the global vitreous tamponades market is valued at US$ 78.3 million in 2023 and is predicted to reach US$ 105.2 million by the end of 2033. In retinal detachment vitrectomy procedures, vitreous tamponades are utilised as postoperative instruments. Vitreous tamponades are widely used to treat several retinal conditions, including retinal detachment, macular hole, epiretinal membrane, retinitis pigmentosa, diabetic retinopathy, retinal degeneration, macular edoema, uveitis, vascular occlusion, and retinopathy of prematurity. Eye surgery called vitreoretinal surgery is performed to treat complications with the retina, vitreous fluid, and macula. Because the eye is an extremely delicate organ and eye surgery needs accuracy, doctors use a variety of aids when performing vitreoretinal procedures. Over the projection period, an increase in vitreoretinal procedures is anticipated to drive demand for vitreous tamponades. Senior patients are more likely to undergo vitreoretinal operations. The demand for vitreoretinal surgeries is anticipated to rise as the world's ageing population increases, which is directly anticipated to drive the sales of vitreous tamponades over the projected period. Download a Free Sample Copy of this Report – Manufacturers of vitreous tamponades could benefit greatly from the rising prevalence of vision disorders. Furthermore, throughout the projection period, it is anticipated that recent technological improvements such as automation and convenience of use of vitreoretinal surgery technologies would enhance the acceptance of vitreous tamponades and raise their sales. North America, followed by Europe, are expected to dominate the global vitreous tamponades market over the decade. Key Takeaways from Market Study Global demand for vitreous tamponades is expected to increase at a CAGR of 3% from 2023-2033.China’s market for vitreous tamponades is predicted to expand at a CAGR of 3% during the projected period.Sales of glass tamponades are expected to rise at a CAGR of 3% during the forecast period.Demand for liquid tamponades is predicted to expand at a CAGR of 3% during the next 10 years. “Rising cases of diabetic retinopathy worldwide is boosting the demand for vitreous tamponades,” says a Fact.MR analyst. Key Segments of Vitreous Tamponades Industry Research By Product : Gaseous TamponadesLiquid TamponadesSilicone OilPerfluorocarbon Liquid By End User : HospitalsOphthalmology ClinicsOthers By Region : North AmericaLatin AmericaEuropeEast AsiaSouth Asia & OceaniaMEA Get Customization on this Report for Specific Research Solutions – Winning Strategy Top market players are highly investing in R&D for the advancements of vitreous tamponades. The leading companies are also focusing on new product launches, collaborations, partnerships, and more to increase their revenue shares. BVI introduced CryoTreq in Europe in April 2020. This handheld cryosurgery tool is intended to be used just once to treat retinal tears and detachments. For retinal tears and detachments, CryoTreq is a minimally-invasive ab externo treatment that provides a substitute for laser photocoagulation, particularly for lesions closer to the forefront of the eye. Competitive Landscape The market is expanding at a very steady pace and to generate more revenue top players are concentrating on developing advanced tamponades, for which they are investing in R&D. Some of the tactics utilized by market participants are new product launches, partnerships, collaborations, and more. For instance, Alcon, Inc. purchased Tear Film Innovations, Inc., a privately held business in 2018 produced the iLux Device, a therapy device used to cure Meibomian Gland Dysfunction, a major cause of dry eye.Kogent Surgical, LLC and Katalyst Surgical, LLC, two producers of surgical tools, were acquired by Carl Zeiss Meditec in April 2022 to improve its position in the market. Key Companies Profiled AL.CHI.MI.A. SrlCarl Zeiss Meditec AGDutch Ophthalmic Research Center International BV (D.O.R.C.)Fluron GmbHNovartis AGValeant Pharmaceuticals International, Inc. Explore Our Safe & Secure Payment Options for Quick Buy – More Valuable Insights on Offer Fact.MR, in its new offering, presents an unbiased analysis of the global vitreous tamponades market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033. The study divulges essential insights on the market on the basis of product (gaseous tamponades, liquid tamponades) and end user (hospitals, ophthalmology clinics), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA). Check out more related studies published by Fact.MR Research: Silicone Gel-Filled Breast Implant Market: Silicone gel-filled breast implants have been approved by the US Food & Drug Administration for breast augmentation among women aged over 22 years. Breast reconstruction is also a lucrative area where silicone gel-filled breast implants seek significant demand, along with their use in the revision surgeries that rectify or improve results of the original surgery. Silicone gel-filled breast implants market is expected to witness bullish prospects as these are not lifetime devices and are associated with periodic replacements. Perfluorocarbons Market: The global perfluorocarbons market, the industry is gaining steady traction, anticipated to expand 1.5x throughout the 2021-2031 assessment period. As per the report, the market is likely to reach US$ 1.4 Bn by the end of the said forecast period. Applications will abound across semiconductor cleaning, cosmetics and medical domains respectively. Embolization Coils Market: The global embolization coils market is expected to surpass an impressive valuation of US$ 1,200 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 5% from 2022 to 2032. Embolization coils are used to treat brain and cardiac aneurysms and other blood-related conditions. Influenza Diagnostics Market: The global influenza diagnostics market was valued at around US$ 2.62 Billion in 2021. Sales of influenza diagnostics tests are projected to accelerate at a CAGR of 5% which will reach US$ 4.5 Billion by 2032. A combination of poor socioeconomic conditions and poor hygiene is responsible for the highest prevalence of influenza in developing nations. Anti-Infective Agents Market: The global anti-infective agents market is expected to be worth US$ 141 Billion in fiscal year 2022, up from US$ 136 Billion in fiscal year 2021. From 2022 to 2032, the market is expected to grow at a 3.3% CAGR, reaching a value of US$ 195.8 Billion by the end of 2032. About Us:We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction. Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership. Contact:US Sales Office:11140 Rockville PikeSuite 400Rockville, MD 20852United StatesEmail: Tel: +1 (628) 251-1583

© 2024